These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 28397481)

  • 1. Diagnosis of Hepatitis C Virus Infection Using a Novel Mouse Monoclonal Antibody to Detect Serum HCV E1/E2 Antigens.
    Touni I; Tabll AA; Sobieh SS; Hewedy MA; Abd YS; Viazov S
    Clin Lab; 2017 Apr; 63(4):669-678. PubMed ID: 28397481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of human clones producing neutralizing human monoclonal antibodies to the envelope E1/E2 protein of hepatitis C virus by EBV immortalization of immune CD22⁺ B cells.
    Tabll A; El Abd Y; El Din NG; El Shenawy R; Abdelhafez TH; El Awady M; El-Mohamady H; Viazov S
    Hum Antibodies; 2013; 22(3-4):55-65. PubMed ID: 24961863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Level of Human Antibodies Targeting HCV E1/E2 Peptides and Spontaneous Clearance of HCV in Blood Donors.
    Tabll AA; Salem EA; El-Abd YS; El-Shenawy RM; Saad A; Abdallah SO; Dawood RM; El-Awady MK
    Clin Lab; 2016 Oct; 62(10):1879-1885. PubMed ID: 28164540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinatal transmission of hepatitis C antigens: envelope 1, envelope 2 and non-structural 4.
    Attallah AM; Abdallah SO; El-Far M; Omran MM; Tabll AA; Ghaly MF; Ezzat SM; Elhamshary MO; El-Gohary ZM; Mohamedin AH; El-Morsi AA; Askora AA; Abdelrazek MA; El-Kafrawy HM; Keneber MH; Khalil MR; Aggag MM; Elbendary MS; El-Deeb MM; Abuzaid MS; Mansour AT; Attallah AA
    Infect Dis (Lond); 2015 Aug; 47(8):568-74. PubMed ID: 25922972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatment.
    Zampino R; Marrone A; Durante Mangoni E; Santarpia L; Sica A; Tripodi MF; Utili R; Ruggiero G; Adinolfi LE
    J Med Virol; 2004 May; 73(1):33-7. PubMed ID: 15042645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection.
    Attallah AM; Ismail H; Tabll AA; Shiha GE; El-Dosoky I
    J Immunoassay Immunochem; 2003; 24(4):395-407. PubMed ID: 14677657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating viral core and E1 antigen levels as supplemental markers for HCV chronic hepatitis.
    El Awady MK; El Abd YS; Shoeb HA; Tabll AA; Hosny Ael D; El Shenawy RM; Atef K; Bader El Din NG; Bahgat MM
    Virol J; 2006 Sep; 3():67. PubMed ID: 16948845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
    Shawky H; Maghraby AS; Solliman Mel-D; El-Mokadem MT; Sherif MM; Arafa A; Bahgat MM
    Arch Virol; 2015 Apr; 160(4):945-58. PubMed ID: 25631616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and methodological evaluation of a chemiluminescence assay for detection of anti-envelope protein (E1, E2) antibodies in the serum of hepatitis C virus-infected patients.
    Wang N; Liu Q; Che F; Sun Q; Wang Y; Yang C; Dai Y; Cheng J
    J Clin Lab Anal; 2024 Feb; 38(4):e25011. PubMed ID: 38491776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of hepatitis C virus envelope proteins expressed in E. coli and insect cells for use as tools for antibody screening.
    Hüssy P; Faust H; Wagner JC; Schmid G; Mous J; Jacobsen H
    J Hepatol; 1997 Jun; 26(6):1179-86. PubMed ID: 9210602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and application of monoclonal antibody against hepatitis C virus nonstructual protein three.
    Shi H; Xie L; Shi H; Yan L; Duan Z
    Hybridoma (Larchmt); 2012 Feb; 31(1):54-9. PubMed ID: 22316486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of differential antibody production against hepatitis C virus in different HCV infection status.
    Rafik M; Bakr S; Soliman D; Mohammed N; Ragab D; ElHady WA; Samir N
    Virol J; 2016 Jun; 13():116. PubMed ID: 27357382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
    Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
    Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.
    Majid AM; Ezelle H; Shah S; Barber GN
    J Virol; 2006 Jul; 80(14):6993-7008. PubMed ID: 16809305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
    J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.
    Beaumont E; Patient R; Hourioux C; Dimier-Poisson I; Roingeard P
    Hepatology; 2013 Apr; 57(4):1303-13. PubMed ID: 23150224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection.
    Zibert A; Kraas W; Ross RS; Meisel H; Lechner S; Jung G; Roggendorf M
    J Hepatol; 1999 Feb; 30(2):177-84. PubMed ID: 10068093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
    Bose M; Mullick R; Das S; Das S; Karande AA
    Virus Res; 2016 Sep; 224():46-57. PubMed ID: 27574733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses to hepatitis C envelope proteins in patients with acute or chronic hepatitis C.
    Fournillier-Jacob A; Lunel F; Cahour A; Cresta P; Frangeul L; Perrin M; Girard M; Wychowski C
    J Med Virol; 1996 Oct; 50(2):159-67. PubMed ID: 8915882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.